Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study
Jonathon W. Senefeld, Patrick W. Johnson, Katie L. Kunze, et al.
PLoS Medicine (2021) Vol. 18, Iss. 12, pp. e1003872-e1003872
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes
Daniele Focosi, Massimo Franchini, Liise-anne Pirofski, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 3
Open Access | Times Cited: 89
Improving clinical care of patients in Nipah outbreaks: moving beyond ‘compassionate use’
Md Zakiul Hassan, Amanda Rojek, Piero Olliaro, et al.
The Lancet Regional Health - Southeast Asia (2025) Vol. 33, pp. 100527-100527
Closed Access | Times Cited: 1
Training Elite Athletes: 50 Years of Thinking About Practice and Research for Endurance Sports
Michael J. Joyner
Scandinavian Journal of Medicine and Science in Sports (2025) Vol. 35, Iss. 1
Closed Access | Times Cited: 1
Guidance on the Use of Convalescent Plasma to Treat Immunocompromised Patients With Coronavirus Disease 2019
Evan M. Bloch, Daniele Focosi, Shmuel Shoham, et al.
Clinical Infectious Diseases (2023) Vol. 76, Iss. 11, pp. 2018-2024
Open Access | Times Cited: 37
Mortality Rates Among Hospitalized Patients With COVID-19 Treated With Convalescent Plasma: A Systematic Review and Meta-Analysis
Jonathon W. Senefeld, Ellen K. Gorman, Patrick W. Johnson, et al.
Mayo Clinic Proceedings Innovations Quality & Outcomes (2023) Vol. 7, Iss. 5, pp. 499-513
Open Access | Times Cited: 28
Overview of autoantibodies in COVID‐19 convalescents
Krystyna Dobrowolska, Dorota Zarębska‐Michaluk, Barbara Poniedziałek, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 6
Closed Access | Times Cited: 26
Convalescent plasma therapy in COVID-19: Unravelling the data using the principles of antibody therapy
Arturo Casadevall, Michael J. Joyner, Liise-anne Pirofski, et al.
Expert Review of Respiratory Medicine (2023) Vol. 17, Iss. 5, pp. 381-395
Closed Access | Times Cited: 25
Antibodies from convalescent plasma promote SARS-CoV-2 clearance in individuals with and without endogenous antibody response
Maddalena Marconato, Irène A. Abela, Anthony Hauser, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 12
Open Access | Times Cited: 32
COVID-19 Therapeutics: Use, Mechanism of Action, and Toxicity (Vaccines, Monoclonal Antibodies, and Immunotherapeutics)
Michael Chary, Alexander F. Barbuto, Sudeh Izadmehr, et al.
Journal of Medical Toxicology (2023) Vol. 19, Iss. 2, pp. 205-218
Open Access | Times Cited: 19
Antibody and B Cell Responses to SARS-CoV-2 Infection and Vaccination: The End of the Beginning
Katharina Röltgen, Scott D. Boyd
Annual Review of Pathology Mechanisms of Disease (2023) Vol. 19, Iss. 1, pp. 69-97
Open Access | Times Cited: 15
Estimates of actual and potential lives saved in the United States from the use of COVID-19 convalescent plasma
Quigly Dragotakes, Patrick W. Johnson, Matthew R. Buras, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 41
Open Access | Times Cited: 5
Post-transfusion activation of coagulation pathways during severe COVID-19 correlates with COVID-19 convalescent plasma antibody profiles
Svenja Weiß, Hung-Mo Lin, Eric Acosta, et al.
Journal of Clinical Investigation (2025) Vol. 135, Iss. 6
Open Access
Vaccine-boosted convalescent plasma therapy for patients with immunosuppression and COVID-19
Juan G. Ripoll, Ellen K. Gorman, Justin E. Juskewitch, et al.
Blood Advances (2022) Vol. 6, Iss. 23, pp. 5951-5955
Open Access | Times Cited: 24
Early antibody treatment, inflammation, and risk of post-COVID conditions
Kelly A. Gebo, Sonya L. Heath, Yuriko Fukuta, et al.
mBio (2023) Vol. 14, Iss. 5
Open Access | Times Cited: 15
Safety of COVID‐19 convalescent plasma: A definitive systematic review and meta‐analysis of randomized controlled trials
Massimo Franchini, Mario Cruciani, Arturo Casadevall, et al.
Transfusion (2023) Vol. 64, Iss. 2, pp. 388-399
Closed Access | Times Cited: 13
Estimates of Actual and Potential Lives Saved in the United States from the use of COVID-19 Convalescent Plasma
Quigly Dragotakes, Patrick W. Johnson, Matthew R. Buras, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
The Potential Role of Passive Antibody-Based Therapies as Treatments for Monkeypox
Evan M. Bloch, David J. Sullivan, Shmuel Shoham, et al.
mBio (2022) Vol. 13, Iss. 6
Open Access | Times Cited: 19
A Clinical Insight on New Discovered Molecules and Repurposed Drugs for the Treatment of COVID-19
Surojit Banerjee, Debadri Banerjee, Anupama Singh, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 332-332
Open Access | Times Cited: 11
Impact of the COVID‐19 pandemic on blood donation and transfusions in the United States in 2020
Sridhar V. Basavaraju, Rebecca J. Free, Joel Chavez Ortiz, et al.
Transfusion (2023) Vol. 63, Iss. S4
Open Access | Times Cited: 10
Convalescent Plasma for Hospitalized COVID-19 Patients: A Single-Center Experience
Massimo Franchini, Claudia Glingani, Giuseppe De Donno, et al.
Life (2022) Vol. 12, Iss. 3, pp. 420-420
Open Access | Times Cited: 15
Convalescent Plasma and the US Expanded Access Program: A Personal Narrative
Michael J. Joyner
Current topics in microbiology and immunology (2024)
Closed Access | Times Cited: 2
Production and Quality Assurance of Human Polyclonal Hyperimmune Immunoglobulins Against SARS-CoV-2
Thierry Burnouf, Birgit Gathof, Evan M. Bloch, et al.
Transfusion Medicine Reviews (2022) Vol. 36, Iss. 3, pp. 125-132
Open Access | Times Cited: 12
Mortality rates among hospitalized patients with COVID-19 treated with convalescent plasma A Systematic review and meta-analysis
Jonathon W. Senefeld, Ellen K. Gorman, Patrick W. Johnson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 7
COVID-19 Serology Data Provide Guidance for Future Deployments of Convalescent Plasma
David J. Sullivan, Arturo Casadevall
mBio (2023) Vol. 14, Iss. 3
Open Access | Times Cited: 7
Managing blood supplies during natural disasters, humanitarian emergencies, and pandemics: lessons learned from COVID-19
Tayler A. Van Denakker, Arwa Z. Al‐Riyami, Rita Feghali, et al.
Expert Review of Hematology (2023) Vol. 16, Iss. 7, pp. 501-514
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top